Structured Review
Averion International
computer generated randomisation schedule
Computer Generated Randomisation Schedule, supplied by Averion International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and morehttps://www.bioz.com/product/computer-generated+randomisation+schedule/computer+generated+randomisation+schedule/pmc04448218-128-13-20
Average 90 stars, based on 1 article reviews
computer generated randomisation schedule - by
Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria"
Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
Journal: The Cochrane Database of Systematic Reviews
doi: 10.1002/14651858.CD006404.pub2
Figure Legend Snippet: Kayentao 2012
Techniques Used: Microscopy, Pregnancy Test (hCG) Assay, Infection, Formulation, Control, Suspension, Sequencing, Selection
Figure Legend Snippet: Poravuth 2011
Techniques Used: Control, Sequencing, Selection
Figure Legend Snippet: Ringwald 1996
Techniques Used: Control, In Vitro, Sequencing, Selection
Figure Legend Snippet: Ringwald 1998
Techniques Used: Control, In Vitro, Sequencing, Selection
Figure Legend Snippet: Rueangweerayut 2012
Techniques Used: Control, Sequencing, Selection, Generated, Introduce
Figure Legend Snippet: Tshefu 2010
Techniques Used: Control, Sequencing, Selection, Generated
Related Articles
Sequencing:Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
Article Snippet: .. Random sequence generation (selection bias) , Low risk , Quote from report: "A computer generated randomisation schedule was provided by Averion AG (Allschwil, Switzerland). Patients were assigned a randomisation code by the investigator in ascending order and allocated to treatment in blocks of nine by study centre.". .. Allocation concealment (selection bias) , Low risk , Quote from report: "Patients were allocated an individual numbered treatment pack containing sufficient tablets for 3 days therapy plus an overage bottle containing an extra dose in case the patient vomited the first dose. Study packages were allocated on the basis of patient randomisation number. A qualified study team member (third party) who was not undertaking clinical assessments opened the study package and administered the correct amount of tablets, based on patient weight at screening, as instructed by the investigator.".
Selection:Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
Article Snippet: .. Random sequence generation (selection bias) , Low risk , Quote from report: "A computer generated randomisation schedule was provided by Averion AG (Allschwil, Switzerland). Patients were assigned a randomisation code by the investigator in ascending order and allocated to treatment in blocks of nine by study centre.". .. Allocation concealment (selection bias) , Low risk , Quote from report: "Patients were allocated an individual numbered treatment pack containing sufficient tablets for 3 days therapy plus an overage bottle containing an extra dose in case the patient vomited the first dose. Study packages were allocated on the basis of patient randomisation number. A qualified study team member (third party) who was not undertaking clinical assessments opened the study package and administered the correct amount of tablets, based on patient weight at screening, as instructed by the investigator.".
Generated:Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
Article Snippet: .. Random sequence generation (selection bias) , Low risk , Quote from report: "A computer generated randomisation schedule was provided by Averion AG (Allschwil, Switzerland). Patients were assigned a randomisation code by the investigator in ascending order and allocated to treatment in blocks of nine by study centre.". .. Allocation concealment (selection bias) , Low risk , Quote from report: "Patients were allocated an individual numbered treatment pack containing sufficient tablets for 3 days therapy plus an overage bottle containing an extra dose in case the patient vomited the first dose. Study packages were allocated on the basis of patient randomisation number. A qualified study team member (third party) who was not undertaking clinical assessments opened the study package and administered the correct amount of tablets, based on patient weight at screening, as instructed by the investigator.".
|